Leonteq Securities AG’s XBiotech XBIT Stock Holding History

Leonteq Securities AG’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,000	Closed	-$112K	–	1350
2022 Q1	$112K	Hold	13,000	–	–	﹤0.01%	709
2021 Q4	$145K	Hold	13,000	–	–	0.01%	697
2021 Q3	$168K	Hold	13,000	–	–	0.01%	625
2021 Q2	$215K	Hold	13,000	–	–	0.01%	557
2021 Q1	$223K	Sell	13,000 -1,000	-7%	-$18.7K	0.01%	531
2020 Q4	$219K	Buy	+14,000	New	+$258K	0.01%	553

Other funds holding XBIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Leonteq Securities AG's XBIT Position: Q2 2022 in Review

Leonteq Securities AG sold out of XBiotech (XBIT) in Q2 2022, closing a stake of 13,000 shares — an estimated $112K sold.

Leonteq Securities AG first reported a position in XBIT in Q4 2020 and held it in 6 quarters. The position peaked at $223K in Q1 2021. 56 funds tracked by Wall St. Rank hold XBIT as of Q2 2022.

Leonteq Securities AG reported no remaining XBiotech position as of Q2 2022 after selling out during the quarter.
Leonteq Securities AG sold 13,000 XBiotech shares in Q2 2022, an estimated $112K.
Leonteq Securities AG first reported a position in XBiotech in Q4 2020 and held it in 6 quarters.
Leonteq Securities AG's XBiotech position peaked at $223K in Q1 2021.
56 funds tracked by Wall St. Rank held XBiotech as of Q2 2022.

Based on Leonteq Securities AG's 13F filing for Q2 2022, filed 26 Mar 2026.